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Abstract
Introduction: Several studies have confirmed the increasing rate of type 1 diabetes mellitus (T1DM) in children and the link
with increasing BMI at diagnosis termed the ‘accelerator hypothesis’. Our objective was to assess whether changing
incidence of type 1 diabetes in a group of children and adolescent from the Midwest United States was associated with
changes in BMI.
Methods: Data from 1618 (52.1% M/47.9% F) newly-diagnosed children and adolescents (,19 years) with T1DM, admitted
to Children’s Hospital of Wisconsin (CHW) between January 1995 and December 2004, was analyzed in relationship to body
mass index (BMI) standard deviation score (SDS).
Results: An overall, 10-year cumulative incidence of 27.92 per 100,000 (19.12 to 41.72/100,000) was observed, with an
average yearly cumulative incidence of 2.39%. The increase was largest in the younger age groups, 0–4, 5–9, and 10–14
having an average yearly increase of 2.4, 2.3, and 3.0%, respectively, corresponding to a relative 10-year increase of 25.3,
33.8, and 38.0%, respectively. Age at diagnosis was inversely correlated with BMI SDS (p,0.001) and remained significant for
both males and females.
Conclusions: Annual incidence of T1DM increased two-fold at CHW over the 10-year study period. The majority of the
increase was observed in the youngest age groups, which also appeared to be the heaviest. This research adds to the
growing literature supporting the hypothesis that excess weight gain during childhood may be a risk factor for early
manifestation of T1DM.
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Introduction
Type 1A diabetes mellitus (T1DM), an autoimmune disorder,
accounts for 10% of diabetes diagnoses, affecting approximately
1.4 million people in the United States (US) and 10–20 million
worldwide [1–3]. In the United States, 30,000 new cases occur
annually and 40% of patients diagnosed are under the age of 20
[2–4]. Recently, studies suggest that the incidence of T1DM may
be on the rise and increasing incidence in younger children is of
the greatest concern.
Incidence rates of pediatric T1DM vary widely throughout the
world. Onkamo et al., (1999) reviewed pooled data from 37 studies
(from 1960 to 1996), and observed an overall 2.8% to 3.0% per
year global increase in incidence of T1DM [5]. However, only one
study, by Kostraba et al., (1992) suggested a slightly negative, but
not significant, trend in T1DM incidence in children and
adolescents [6]. The World Health Organization’s DIAMOND
study reported incidence rates from over 100 Centers ranging
from 0.1/100,000 per year in China and Venezuela to 37.8/
100,000 per year in Sardinia and 42.9/100,000 per year in
Finland [2]. A large number of studies have been published
supporting the rising incidence of T1DM, especially in the
younger age groups [7–19]. One of the most notable and recent,
in the United States, includes a population-based study of
incidence rates of T1DM from 10 study locations by The
SEARCH for Diabetes in Youth Study. The Search Group found
an overall incidence of T1DM in children 0–19 of 24.3 per
100,000 person years with the highest rates observed among the
5–9 and 10–14 age groups with rates of 22.9 and 33.9 per 100,000
respectively [14]. There is still some speculation as to whether
there is also an increase in incidence in the older adolescent
groups.
While the autoimmune nature of T1DM continues to be under
investigation [20,21], the underlying mechanisms responsible for
the rise of T1DM, especially in the younger age groups, remain
unknown. However, the ‘‘accelerator hypothesis’’ proposed by
Wilkin, is one of the more compelling theories [22–24]. This
investigator suggested that increasing body weight in younger
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developing T1DM. In fact, an inverse relationship was found
between age at diagnosis and body mass index (BMI) at diagnosis
and at 12 months after diagnosis, as well as weight at diagnosis and
weight change since birth. Essentially, the age at diagnosis
becomes younger as children become heavier; suggesting that
being overweight accelerates insulin resistance, leading to the
development of T1DM in genetically-predisposed individuals.
Thereafter a number of papers have been published supporting
Wilkin’s accelerator hypothesis’ [24–30]. A study by Libman et al.,
(2003) in the United States showed an overall significant increase
in the prevalence of being overweight in children with T1DM
from 12.6% (1979–1989) to 36.8% (1990–1998). However, the
older adolescent population (.11 years) was more overweight than
the younger children [31]. To date, the role of increasing body
weight in very young children as a risk factor for early
development of T1DM remains inconclusive.
The increase in incidence of T1DM in younger age groups in
relation to increasing BMI has not been confirmed in the
literature. Therefore, we set out to determine the changing
burden of T1DM in specific age cohorts in relationship to BMI
and body weight at diagnosis in Southeastern Wisconsin.
Methods
Ethics Statement
This study was approved by the institutional review board (IRB)
of Children’s Hospital Wisconsin for the retrospective review of
patients’ clinic charts and, therefore, no informed consent was
required. Details that might disclose the identity of the subjects
were omitted from data collection.
Subjects
Data from 1618 children and adolescents with newly diagnosed
T1DM, who were evaluated (inpatients and outpatients) at
Children’s Hospital of Wisconsin (CHW) Diabetes Center
(affiliated with Medical College of Wisconsin) between January
1995 and December 2004, were included in the study. Children’s
Hospital of Wisconsin is the primary source for pediatric diabetes
care in the region of Southeastern Wisconsin. No more than 2.8%
of all pediatric admissions for any disease are seen at the other 10
area hospitals. Referral rates for new onset patients with diabetes
from primary care physicians remained the same throughout the
10-year study period [32]. Therefore, we ascertain that we
identified the majority of pediatric patients with new-onset T1DM.
The diagnosis of T1DM was ascertained based on physician
diagnosis extracted from chart review. Patients with a physician-
diagnosis of Type 2 Diabetes Mellitus or other endocrinology
disorder were excluded from the study. We cross-referenced the
hospital medical records with clinic medical records to make sure
that we had captured all the diabetes patients. The date of
admission (date of diagnosis), date of birth, gender, race, diabetic
ketoacidosis status at diagnosis, weight, height, BMI, and medical
identification number for each patient were extracted from the
patients medical record. Growth parameters were assessed at initial
evaluation (admission to hospital), including height, weight, and
bodymass index (BMI, kg/m
2). BMIwas calculated byusing weight
and height, which were normalized for age and sex by calculating
standard deviation scores (SDS) (z-scores) using 2000 Centers for
Disease Control and Prevention (CDC) growth charts as a reference
standard. Body mass index (BMI) and SDS calculations were
determined using the Epi Info nutrition calculator [33].
Subjects were divided into four age cohorts according to age at
diagnosis: 0–4, 5–9, 10–14, and 15–19 years and further divided
into BMI percentile categories: underweight (#5
th), normal (6
th–
85
th), overweight (86
th–95
th), obese ($96
th) [34]. The denominator
for the analysis was the number of children 0–19 years of age who
were located within the 8-county (population: 586,080) study
region of SE Wisconsin [35]. This region was chosen by mapping
the T1DM patients by zip code. The overall age- and sex-adjusted
incidence rates were calculated using the yearly US census data
[36].
Statistical Analysis
Initial descriptive analysis was conducted to summarize data.
Data is expressed as mean6SE when appropriate. Rates were
calculated using yearly census data. BMI and weight were
converted into SDS. SDS is a type of z-score that normalizes
age and sex of the research population based on 2000 CDC
growth charts. Linear and logistic multivariate regression was used
to determine which variables were associated with BMI for age
SDS. Variables introduced into the regression analysis included
sex, age at diagnosis, year of diagnosis, and presence of
ketoacidosis. A p-value of less than or equal to 0.05 was considered
significant. Statistical analysis was conducted by using NCSS [37].
Results
A total of 1618 (52.1% male; 47.9% female) new cases of
T1DM were identified among children aged 0–19 during the
study period. The ethnic distribution was 80.1% Caucasians
(n=1296), 10.8% African Americans (n=175), 4.2% Hispanic
(n=68), and 4.9% other ethnicities (Asians/Inuit Indians) (n=79).
The overall cumulative incidence from 1995 to 2004 was 27.92/
100,000 (95% CI: 262.8–289.8) (from 19.12 to 41.72/100,000;
p=0.006) for SE Wisconsin. Males have a slightly higher overall
10-year incidence than females. A significant increase in the
second half of the study period, between 2000 and 2004, from
23.54 per 100,000 a year to 41.72 per 100,000 per year was found,
which corresponds with an increase of 20% for this five-year
period (p,0.001) as seen in table 1.
The increase in incidence was largest in the younger age groups.
The children aged 0–4, 5–9, and 10–14 years, had an increase of
2.4, 2.3, and 3.0% per year, respectively and an overall 10-year
relative increase of 25.3, 33.8, and 38.0%, respectively. In the
older children (15–19 years), the increase was 1.8% per year with
an overall 10-year relative increase of 14.0% as seen in figure 1.
A similar increase was seen in both males and females. Females
had a slightly higher mean incidence in the younger age groups (0–
4 and 5–9 years), and males had a higher mean incidence in the
older age groups (10–14 and 15–19 years). Additionally, we
calculated the proportion of children and adolescents with BMI
SDS above 86
th (overweight) and 96
th (obese) percentiles from
1999 to 2004. Twenty-eight point four were considered either
overweight or obese in this cohort with children #9 years,
accounting for 60.3 (BMI SDS) and 55.2% (weight SDS) of newly-
diagnosed T1DM patients in this category. There also appeared to
be a sharp increase in the number of children both overweight and
obese during the second five-year period. In fact, the combined
rate of overweight (.86
th percentile for age) and obese (.96
th
percentile for age) was significantly increased in the period 2000–
2004 for 0–4 year (p=0.007) and 5–9 year (p=0.007) age groups,
but not for the remainder of the cohort as seen in figure 2.
In the entire cohort, BMI SDS at diagnosis and weight for age
were highly correlated (r=0.61, p,0.001). There were inverse
and statistically significant relationships for BMI SDS (p,0.001) at
diagnosis in relation to age at diagnosis, based on F-statistic one-
way ANOVA. BMI SDS remained significant when separating
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regression analysis was performed, and BMI SDS was selected
(BMI SDS, p=0.037). In the multiple regression models when
using age at diagnosis as the dependent variable, BMI SDS
remained significant (BMI r=0.19, p=0.04). Age at diagnosis
remained significant when using weight SDS as the dependent
variable (p,0.001). Although when BMI SDS was used as the
dependent variable, age at diagnosis was no longer significant
(p=0.15). penultimate.
Discussion
Our study results suggest that the overall incidence of T1DM in
SE Wisconsin increased two-fold from 1995 to 2004. The largest
Figure 1. Overall 10-year age (0–19 years) and gender specific incidence. Incidence calculated by using yearly U.S census data for 8 county
metro area [35].
doi:10.1371/journal.pone.0006873.g001
Table 1. Yearly incidence (0–19 yrs) of Type 1 DM from 1995 to 2004 in Southeastern Wisconsin.
Year ALL Cases ALL Incidence Males Cases Males Incidence Female Cases Female Incidence
1995 110 18.8 57 19.02 53 18.51
1996 126 21.5 65 21.69 61 21.3
1997 117 20.0 65 21.69 52 18.16
1998 120 20.5 55 18.35 65 22.7
1999 135 23.0 73 24.35 62 21.65
2000 138 23.5 78 26.02 60 20.95
2001 181 30.9 86 28.69 95 33.18
2002 214 36.5 117 39.03 97 33.88
2003 241 41.1 120 40.04 121 42.26
2004 236 40.3 127 42.37 109 38.07
1995–1999 608 103.7 315 105.1 293 102.3
2000–2004 1010 172.3 528 176.2 482 168.3
1995–2004 1618 276.0 843 281.3 775 270.6
*Incidence calculated by using yearly U.S census data for 8 county metro area [35].
doi:10.1371/journal.pone.0006873.t001
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groups of 0–4, 5–9 and 10–14 years, which is consistent with other
studies published included the SEARCH group [7–19]. Similar to
previous studies, females had a slightly higher mean incidence in
the younger age groups (0–4 and 5–9 years) than males, whereas
males had higher mean incidence than females in the older age
groups (10–14 and 15–19 years) [7–19]. Indeed, the incidence of
T1DM in our cohort in 2004 appeared to be similar to that
observed in Finland [9] and the SEARCH Group [14].
Furthermore, the youngest age groups seem to also be the
heaviest, in relation to BMI SDS. This relationship seemed to
become more prevalent throughout the 10-year study period. Our
cohort had a slightly higher number of children and adolescents
considered overweight (19.7, BMI SDS; 21.8, weight SDS) and
obese (8.53, BMI SDS; 12.67, weight SDS) as compared to the
State of Wisconsin’s averages of 14 overweight and 10 percent
obese [38].
Wilkin (2001) suggested that three accelerators might be
responsible: an impending b-cell death, insulin resistance, and a
genetic propensity to develop b-cell autoimmunity [22]. Recently,
Knerr et al., (2005) also reported that higher BMI was associated
with a younger age at diabetes onset in a large cohort of German
and Austrian children with T1DM [28]. In our cohort, there was
not only an inverse relationship between the age of diagnosis and
BMI SDS, but also a two-fold increase in BMI SDS from our
second five-year period (2000–2004) in all of the age cohorts as
compared with the first five-year period (1995–1999). This
increase corresponded with a 20% increase in the proportion of
newly-diagnosed children with T1DM during the same period
(2000–2004).
There were a number of limitations to this study. First, case
ascertainment methods were limited. Cross-reference of all
patients diagnosed with diabetes in the hospital medical records
was compared with clinic ‘‘shadow’’ records to ascertain that we
had captured all the diabetes patients and to verify the T1DM
diagnosis. Children’s Hospital of Wisconsin (CHW) provides in-
patient care to 86% to 90% of pediatric population in the SE
Wisconsin region [35]. Consequently, CHW Diabetes Center is
believed to capture similar percentages of children and adolescents
with T1DM, therefore we believe that our results can be
generalizable to other pediatric populations. The referral rates to
this hospital for ‘‘all treatments’’ and specifically for ‘‘diabetes’’
remained constant during the 10-year study period. In order to
verify that the children in our cohort corresponded with the 8-
county metro area we mapped the zip codes recorded in their
medical records. Secondly, we were only able to collect one point
of height and weight data at diagnosis, which doesn’t take into
account the possibility of weight loss due to symptoms related to
the onset of the diabetes. Therefore, it would have been more
meaningful if weight and height data from six months before or
after diagnosis were available to evaluate the relationship between
age at onset and body weight. Thirdly, we were not able to
evaluate b-cell function and number of diabetes antibodies in
relationship to age at diagnosis and body weight. Indeed, obesity-
Figure 2. Rates of BMI SDS above 85th (overweight & obese) percentiles for each 5-year period (1995–1999 and 2000–2004) by age.
Incidence calculated by using yearly U.S census data for 8 county metro area [35].
doi:10.1371/journal.pone.0006873.g002
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which become susceptible to an autoimmune attack [39]. These
limitations would suggest that our data may be an under-
representation of the number of children newly diagnosed with
T1DM.
Our study was the first 10-year retrospective cohort in the
Midwest, looking at the burden of T1DM and the relationship
with BMI. Our findings suggest that the overall incidence of
T1DM is increasing in Southeastern Wisconsin, with the largest
increase seen in children #14 years of age. A likely mechanism for
this increase is an increase in weight gain at diagnosis, namely
‘‘accelerator hypothesis’’ [22].
Our research adds to the growing literature that emphasizes the
importance of maintaining a healthy weight throughout child-
hood; which could delay the onset on T1DM into adolescence.
Indeed, our data reaffirms that excess weight during early
childhood could be an important mechanism in understanding
the etiology of T1DM.
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